Cargando…
Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
The dose-response model has been widely used for quantifying the risk of infection of airborne diseases like COVID-19. The model has been used in the room-average analysis of infection risk and analysis using passive scalars as a proxy for aerosol transport. However, it has not been employed for ris...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249924/ https://www.ncbi.nlm.nih.gov/pubmed/35778513 http://dx.doi.org/10.1038/s41598-022-14862-y |
_version_ | 1784739696427925504 |
---|---|
author | Bale, Rahul Iida, Akiyoshi Yamakawa, Masashi Li, ChungGang Tsubokura, Makoto |
author_facet | Bale, Rahul Iida, Akiyoshi Yamakawa, Masashi Li, ChungGang Tsubokura, Makoto |
author_sort | Bale, Rahul |
collection | PubMed |
description | The dose-response model has been widely used for quantifying the risk of infection of airborne diseases like COVID-19. The model has been used in the room-average analysis of infection risk and analysis using passive scalars as a proxy for aerosol transport. However, it has not been employed for risk estimation in numerical simulations of droplet dispersion. In this work, we develop a framework for the evaluation of the probability of infection in droplet dispersion simulations using the dose-response model. We introduce a version of the model that can incorporate the higher transmissibility of variant strains of SARS-CoV2 and the effect of vaccination in evaluating the probability of infection. Numerical simulations of droplet dispersion during speech are carried out to investigate the infection risk over space and time using the model. The advantage of droplet dispersion simulations for risk evaluation is demonstrated through the analysis of the effect of ambient wind, humidity on infection risk, and through a comparison with risk evaluation based on passive scalars as a proxy for aerosol transport. |
format | Online Article Text |
id | pubmed-9249924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-92499242022-07-03 Quantifying the COVID19 infection risk due to droplet/aerosol inhalation Bale, Rahul Iida, Akiyoshi Yamakawa, Masashi Li, ChungGang Tsubokura, Makoto Sci Rep Article The dose-response model has been widely used for quantifying the risk of infection of airborne diseases like COVID-19. The model has been used in the room-average analysis of infection risk and analysis using passive scalars as a proxy for aerosol transport. However, it has not been employed for risk estimation in numerical simulations of droplet dispersion. In this work, we develop a framework for the evaluation of the probability of infection in droplet dispersion simulations using the dose-response model. We introduce a version of the model that can incorporate the higher transmissibility of variant strains of SARS-CoV2 and the effect of vaccination in evaluating the probability of infection. Numerical simulations of droplet dispersion during speech are carried out to investigate the infection risk over space and time using the model. The advantage of droplet dispersion simulations for risk evaluation is demonstrated through the analysis of the effect of ambient wind, humidity on infection risk, and through a comparison with risk evaluation based on passive scalars as a proxy for aerosol transport. Nature Publishing Group UK 2022-07-01 /pmc/articles/PMC9249924/ /pubmed/35778513 http://dx.doi.org/10.1038/s41598-022-14862-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Bale, Rahul Iida, Akiyoshi Yamakawa, Masashi Li, ChungGang Tsubokura, Makoto Quantifying the COVID19 infection risk due to droplet/aerosol inhalation |
title | Quantifying the COVID19 infection risk due to droplet/aerosol inhalation |
title_full | Quantifying the COVID19 infection risk due to droplet/aerosol inhalation |
title_fullStr | Quantifying the COVID19 infection risk due to droplet/aerosol inhalation |
title_full_unstemmed | Quantifying the COVID19 infection risk due to droplet/aerosol inhalation |
title_short | Quantifying the COVID19 infection risk due to droplet/aerosol inhalation |
title_sort | quantifying the covid19 infection risk due to droplet/aerosol inhalation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249924/ https://www.ncbi.nlm.nih.gov/pubmed/35778513 http://dx.doi.org/10.1038/s41598-022-14862-y |
work_keys_str_mv | AT balerahul quantifyingthecovid19infectionriskduetodropletaerosolinhalation AT iidaakiyoshi quantifyingthecovid19infectionriskduetodropletaerosolinhalation AT yamakawamasashi quantifyingthecovid19infectionriskduetodropletaerosolinhalation AT lichunggang quantifyingthecovid19infectionriskduetodropletaerosolinhalation AT tsubokuramakoto quantifyingthecovid19infectionriskduetodropletaerosolinhalation |